Bendroflumethiazide + Potassium
Fixed-dose combination
This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.
Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.
Active ingredients
- Bendroflumethiazide
bendroflumethiazide - Potassium
potassium
Brands with this exact combination
| Brand | Dose | Manufacturer |
|---|---|---|
| Neo-Naclex-K modified-release tabletsGB | 2.5 mg / 630 mg | Mercury Pharma Group Ltd |
| Bendroflumethiazide 2.5mg / Potassium chloride 630mg (potassium 8.4mmol) modified-release tabletsGB | 2.5 mg / 630 mg | Mercury Pharma Group Ltd |
| Centyl K modified-release tabletsGB | 2.5 mg / 573 mg | LEO Pharma |
| Bendroflumethiazide 2.5mg / Potassium chloride 573mg (potassium 7.7mmol) modified-release tabletsGB | 2.5 mg / 573 mg | LEO Pharma |
Same combination in other markets
No product with this combination is recorded in the other covered markets yet.
See warnings for these ingredients
Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.